Skip to content

Depression: all studies

Page 113 of 1,034: studies 1,121 to 1,130 of 10,336, newest first. Back to the depression overview

Research

Spravato for Treatment-Resistant Depression: Efficacy and Sexual Side Effect Profile.

Neuropsychiatric Disease and Treatment 2025 Ahmed Asad Raza, Ghazi Uddin Ahmed, Habiba Zafar et al. 6 citations

Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD) are debilitating psychiatric conditions associated with significant psychosocial and economic burdens. Conventional antidepressants, particularly SSRIs and SNRIs, often produce inadequate responses and cause sexual dysfunction, contributing to poor adherence and diminished quality of life. This review aims to evaluate the...

Ketamine or Electroconvulsive Therapy as Treatment Approach to Severe Depression: The Necessity of More Personalized Management

Ketamine 2025 Pouya Movahed Rad, Akihiro Takamiya

Depression is a debilitating psychiatric disorder. Electroconvulsive therapy (ECT) and ketamine are effective treatments for severe depression, but target populations may differ. Systematic reviews on the few available trials show higher remission rates with ECT than with ketamine. Nonetheless, ketamine’s rapid onset of action is comparable to ECT but with less cognitive adverse effects. This...

Key Considerations for Practical Administration of Ketamine in Severe Depression, and Its Use in Community Care in Edmonton, AB, Canada

Ketamine 2025 Carson Chrenek, Jennifer Swainson

Although both intranasal esketamine and intravenous ketamine have proven efficacy and tolerability in treatment-resistant depression (TRD), patient access to these treatments is often limited due to cost, availability, and/or monitoring requirements. This article is intended to provide a synthesis of the current literature with regard to the pharmacologic use of ketamine in TRD and describe its...

Modulation of functional network co-activation pattern dynamics following ketamine treatment in major depression.

Imaging Neuroscience 2025 Brandon Taraku, Jason S Nomi, Artemis Zavaliangos-Petropulu et al.

Ketamine produces fast-acting antidepressant effects in treatment-resistant depression (TRD). Prior studies have shown altered functional dynamics between brain networks in major depression. We thus sought to determine whether functional brain network dynamics are modulated by ketamine therapy in TRD. Participants with TRD (n = 58, mean age = 40.7 years, female = 48.3%) completed resting-state...

Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.

General Hospital Psychiatry 2025 Yvan Beaussant, Elise C. Tarbi, Kabir Nigam et al. 3 citations

Psilocybin-assisted therapy (PAT) shows promise for cancer-related depression, yet little research has examined how therapeutic context shapes patient experiences. While set (mindset) and setting (environment) are considered central to psychedelic treatment, empirical evidence on their role in PAT acceptability remains limited. This study explores factors influencing the acceptability of PAT...

Brain changes associated with depression treatment: a meta-analysis

NeuroImage: Clinical 2025 Gianna M. Perez, Benjamin M. Rosenberg, Wenyi Xu et al. 3 citations

BACKGROUND: Understanding changes in brain activity following treatment is critical to advancing the use of neuroimaging in psychiatric research. Previous work has focused on defining abnormalities (biomarkers) between patients and healthy controls but there has been less investigation of brain changes in depression patients following treatment. To boost sample size and explore the possibility...

Structural Pharmacology of Bufotenine Derivatives in Activating the 5-HT 1A Receptor for Therapeutic Potential in Depression and Anxiety

Research 2025 Shujie Li, Shu-Jie Li, Qingning Yuan et al.

The 5-HT 1A receptor is a critical target in the treatment of depression and anxiety. Bufotenine derivatives, such as 5-methoxy- N , N -dimethyltryptamine (5-MeO-DMT), 5-hydroxy- N , N -dimethyltryptamine (5-OH-DMT), and 5-hydroxy- N , N , N -dimethyltryptamine—derived from traditional Chinese medicine—have shown antidepressant potential. However, the structural basis of their interaction with...

Acceptance and commitment therapy for psychiatric inpatients diagnosed with depression and insomnia: a multiple-baseline single-case study.

Frontiers in Psychiatry 2025 Zrinka Sosic-Vasic, Max Bergmann, Julia Kroener

The overarching goal of ACT is to increase psychological flexibility, which can be enhanced through mechanisms such as acceptance, valued-driven actions, or mindfulness. Several meta-analyses confirm the effectiveness of Acceptance and Commitment Therapy (ACT) in the treatment of clinical and subclinical populations, including patients diagnosed with depressive disorder and insomnia, largely...

Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?

Trends in Psychiatry and Psychotherapy 2025 Elena Koning, Pedro Starzynski Bacchi, Cristiano Chaves et al.

Although each PAP model differs, both may have clinical relevance in depression treatment. Future work should explore the standardized reporting of psychological interventions in PAP and comparative study designs to better evaluate non-specific and specific models and inform treatment guidelines.

DOI: 10.47626/2237-6089-2025-1197 (opens in new tab) Full text (opens in new tab) Psilocybin Psychological intervention Relevance law Depression economics +5

Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD

Open Science Framework 2025 Mackenzie Hancock, Shambhu Prasad Adhikari, Nicole Getz preprint

This scoping review examines the emerging evidence for psilocybin-assisted therapy (PAP) in treating trauma-related disorders such as posttraumatic stress disorder (PTSD), depression, and persistent post-concussion symptoms (PPCS), with specific implications for intimate partner violence (IPV)-related brain injury and PTSD. Guided by PRISMA-ScR methodology, we systematically searched Medline,...

DOI: 10.17605/osf.io/ar2s4 (opens in new tab) Domestic violence Posttraumatic stress Psychotherapist Clinical psychology +10